Cargando…
Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system
BACKGROUND: Myocardial infarction (MI) is one of the most common ischemic heart diseases. It is very essential to explore new types of cardioprotective drugs delivery systems in this area. OBJECTIVE: The aim of the present study was to investigate the protective effect of baicalin (BA) and puerarin...
Autores principales: | Wang, Jie, Zhang, Shouwen, Di, Lizhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525923/ https://www.ncbi.nlm.nih.gov/pubmed/34662253 http://dx.doi.org/10.1080/10717544.2021.1989086 |
Ejemplares similares
-
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
por: Zhang, Shouwen, et al.
Publicado: (2018) -
Atrial Natriuretic Peptides, Right Atrial Infarction and Prognosis of Patients with Myocardial Infarction—A Single-Center Study
por: Kacprzak, Michal, et al.
Publicado: (2021) -
Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation
por: Yu, Jianjun, et al.
Publicado: (2018) -
Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction
por: Yildirim, Tarik, et al.
Publicado: (2018) -
Protective Effects of Baicalin on Experimental Myocardial Infarction
in Rats
por: Wang, Longfei, et al.
Publicado: (2018)